Thulium laser enucleation versus plasma kinetic resection of the prostate in the treatment of benign prostatic hyperplasia
10.13263/j.cnki.nja.2024.06.005
- VernacularTitle:前列腺铥激光剜除术与等离子电切术治疗良性前列腺增生的对比研究
- Author:
Wei-Dong ZHANG
1
;
Wen-Jia WANG
;
Zhi-Qiang SONG
;
Zhe MA
;
Jia-Wei ZHANG
;
Hao-Hao WANG
;
Jian-Chen WU
Author Information
1. 清华大学第一附属医院泌尿外科,北京 100016
- Keywords:
benign prostatic hyperplasia;
thulium laser enucleation of the prostate;
plasma kinetic resection of the prostate;
complication
- From:
National Journal of Andrology
2024;30(6):514-518
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To compare thulium laser enucleation of the prostate(ThuLEP)with plasma kinetic resection of the prostate(PKRP)in the treatment of BPH.Methods:We retrospectively analyzed the medical records of 160 cases of BPH treated by ThuLEP(the observation group,n=80)or PKRP(the control group,n=80)in our hospital from January 2021 to December 2023.We recorded the operation time,bladder irrigation time,catheter retention time,hospitalization time,postoperative complica-tions,and pre-and postoperative maximum urinary flow rate(Qmax),residual urine volume(PVR),prostate-specific antigen(PSA)and prostate volume,followed by comparison of the data obtained between the two groups of patients.Results:Compared with the controls,the patients of the observation group showed significantly shorter operation time([67.25±7.24]vs[60.10±5.15]min,P<0.05),bladder irrigation time([46.90±10.77]vs[43.24±6.65]h,P<0.05),catheterization time([5.60±1.31]vs[5.03±1.24]d,P<0.05)and hospitalization time([7.31±2.00]vs[6.55±1.67]d,P<0.05),higher Qmax([18.50±1.24]vs[20.68±1.45]ml/s,P<0.05),lower PVR([12.10±3.53]vs[10.82±3.10]ml,P<0.05),PSA([4.60±0.78]vs[3.38±0.40]μg/L,P<0.05)and prostate volume([25.35±6.46]vs[20.12±5.13]ml,P<0.05)at 3 months after surgery,but no statistically significant difference in the total incidence of postoperative complications(7.50%[6/80]vs 5.00%[4/80],P>0.05).Conclusion:ThuLEP,with its advantages of notable effect,short operation and hospitaliza-tion time,significant improvement of urinary flow dynamics and prostate function,deserves clinical promotion for the treatment of BPH.
